Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis

doi:10.3748/wjg.v24.i30.3361

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 30

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (24911)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

3886

HTML

18819

Figures (1-2)

257

Tables (1-5)

174

Sum=23136

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

920

Download

855

Sum=1775

Aug 14, 2018 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (355)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Aug 14, 2018; 24(30): 3361-3373
Published online Aug 14, 2018. doi: 10.3748/wjg.v24.i30.3361

Table 2 Comparative analysis of the recommendations regarding the screening for non-alcoholic fatty liver disease

	EASL	NICE	Asia-Pacific	AISF	AASLD
Systematic screening	No	No	No	No	No
Screening in high-risk groups	Yes	Yes	Yes	Not mentioned	No¹
	Obesity	Obesity	Obesity
	Metabolic syndrome	Type II Diabetes	Type II Diabetes
	Abnormal liver enzymes
Screening modality	Yes liver enzymes	No liver enzymes	No liver enzymes
		Yes ultrasonography	Yes ultrasonography
			Yes transient elastography

¹"Active surveillance" (but not screening) suggested for patients with type II diabetes mellitus. EASL: European Association for the Study of the Liver; NICE: National Institute for Health and Care Excellence; AISF: Italian Association for the Study of the Liver; AASLD: American Association for the Study of Liver Diseases.

Citation: Leoni S, Tovoli F, Napoli L, Serio I, Ferri S, Bolondi L. Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis. World J Gastroenterol 2018; 24(30): 3361-3373
URL: https://www.wjgnet.com/1007-9327/full/v24/i30/3361.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i30.3361